JNJ-64619178 (Synonyms: Onametostat) |
رقم الكتالوجGC19465 |
JNJ-64619178 (Onametostat) هو مثبط انتقائي ، نشط شفويا وغير قابل للانعكاس بروتين أرجينين ميثيل ترانسفيراز 5 (PRMT5) مع IC50 من 0.14 نانومتر. JNJ-64619178 له نشاط قوي في سرطان الرئة.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2086772-26-9
Sample solution is provided at 25 µL, 10mM.
JNJ-64619178 is a PRMT5 inhibitor with high selectivity and potency (PRMT5-MEP-50, IC50=0.14 nM), good pharmacokinetic properties and safety.
JNJ-64619178 can be combined with a SAM binding pocket to inhibit the function of PRMT/MEP50 in a time-dependent manner. Various cell lines exhibited different degrees of sensitivity to JNJ-64619178, indicating that JNJ-64619178 inhibits PRMT5 mainly by genomic rather than general targeted cytotoxicity [1].
The methylation of SMD1/3 protein can be selectively and effectively prevented by oral administration of 10 mg/kg JNJ-64619178 per day. SMD1/3 is a key component of the splice and a substrate for PRMT5/MEP50. In the biomarker-driven human small cell lung cancer xenograft model (NCI-H1048), JNJ-64619178 can cause tumor regression and prolong tumor growth inhibition after termination of administration [1].
Reference:
[1] Dirk Brehmer, et al. 108th Annu Meet Am Assoc Cancer Research
Average Rating: 5
(Based on Reviews and 24 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *